Obesity paradox and lung cancer, metformin-based therapeutic opportunity?

Oncotarget. 2023 Jul 1:14:670-671. doi: 10.18632/oncotarget.28432.
No abstract available

Keywords: BMI; EGFR; metformin; obesity paradox; tyrosine-kinase inhibitors.

Publication types

  • Editorial

MeSH terms

  • Body Mass Index
  • Carcinoma, Non-Small-Cell Lung* / drug therapy
  • Humans
  • Lung Neoplasms* / drug therapy
  • Metformin* / therapeutic use
  • Obesity Paradox

Substances

  • Metformin